Provided is a charge-transporting varnish which comprises an amide compound containing fluorine atoms and represented by formula (1) and a charge-transporting substance. ##STR00001##
[In the formula, Ar.sup.1 represents a group represented by any of formulae (1-1) to (1-9) and Ar.sup.2 and Ar.sup.3 each represent a given fluorinated aryl or aralkyl group.] ##STR00002##

The present invention provides cationic lipids and lipid nanoparticle formulations comprising these lipids, alone or in combination with other lipids. These lipid nanoparticles may be formulated with nucleic acids to facilitate their intracellular delivery both in vitro and for therapeutic applications. The present invention also provides methods of chemical synthesis of these lipids, lipid nanoparticle preparation and formulation with nucleic acids.

A composition in the form of an injectable aqueous solution, wherein the pH is comprised from 6.0 to 8.0, includes at least:

a) amylin, an amylin receptor agonist or an amylin analog; and

b) a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Hy, wherein the composition does not comprise a basal insulin wherein the isoelectric point pI is comprised from 5.8 to 8.5. The composition may further include a prandial insulin.

Cohesive carbon assemblies are prepared by obtaining a functionalized carbon starting material in the form of powder, particles, flakes, loose agglomerates, aqueous wet cake, or aqueous slurry, dispersing the carbon in water by mechanical agitation and/or refluxing, and substantially removing the water, typically by evaporation, whereby the cohesive assembly of carbon is formed. The method is suitable for preparing free-standing, monolithic assemblies of carbon nanotubes in the form of films, wafers, discs, fiber, or wire, having high carbon packing density and low electrical resistivity. The method is also suitable for preparing substrates coated with an adherent cohesive carbon assembly. The assemblies have various potential applications, such as electrodes or current collectors in electrochemical capacitors, fuel cells, and batteries, or as transparent conductors, conductive inks, pastes, and coatings.

Cohesive carbon assemblies are prepared by obtaining a functionalized carbon starting material in the form of powder, particles, flakes, loose agglomerates, aqueous wet cake, or aqueous slurry, dispersing the carbon in water by mechanical agitation and/or refluxing, and substantially removing the water, typically by evaporation, whereby the cohesive assembly of carbon is formed. The method is suitable for preparing free-standing, monolithic assemblies of carbon nanotubes in the form of films, wafers, discs, fiber, or wire, having high carbon packing density and low electrical resistivity. The method is also suitable for preparing substrates coated with an adherent cohesive carbon assembly. The assemblies have various potential applications, such as electrodes or current collectors in electrochemical capacitors, fuel cells, and batteries, or as transparent conductors, conductive inks, pastes, and coatings.

An object of the present invention is to provide a chemical liquid having excellent defect inhibition performance and a chemical liquid storage body. The chemical liquid according to an embodiment of the present invention is a chemical liquid containing an organic solvent that has a conductivity equal to or lower than 10.sup.?5 S/m at 25? C., and a compound represented by General Formula (I), in which a content of the compound represented by General Formula (I) with respect to the total mass of the chemical liquid is 0.10 mass ppt to 100,000 mass ppt. ##STR00001##

The present invention provides a method for preparing a high-performance graphite sheet by imidizing a polyamic acid resulting from a reaction of dianhydride monomer(s) and diamine monomer(s) to obtain a polyimide film; and carbonizing and/or graphitizing the polyimide film to obtain a high-performance graphite sheet, where the polyimide film contains 2 or more fillers having different average particle diameters, and the thermal conductivity of the graphite sheet is at least 1,400 W/m.Math.K. Further, the present invention provides a graphite sheet obtained by the above method.

Provided are a heterocyclic carboxylic acid amide ligand and applications thereof in a copper catalyzed coupling reaction. Specifically, provided are uses of a compound represented by formula (I), definitions of radical groups being described in the specifications. The compound represented by formula (I) can be used as the ligand in the copper catalyzed coupling reaction of the aryl halogeno substitute, and is used or catalyzing the coupling reaction for forming the aryl halogeno substitute having CN, CO, CS and other bonds.

##STR00001##

Novel dissymmetric N,N-dialkylamides which meet the following formula (I): ##STR00001##
where R represents a linear or branched alkyl group at C.sub.8 to C.sub.15. A method for synthesizing these N,N-dialkylamides, and to the uses of same as extractants, alone or in admixture, in order to extract uranium and/or plutonium from an aqueous acid solution, or to totally or separate uranium from plutonium from an aqueous acid solution and, in particular, an aqueous solution resulting from dissolving spent nuclear fuel in nitric acid. Further, a method for processing an aqueous solution resulting from the dissolution of a spent nuclear fuel in nitric acid, allowing the uranium and plutonium contained in the solution to be extracted, separated and decontaminated in a single cycle, without requiring any plutonium reduction operation, and in which one of the aforementioned N,N-dialkylamides or a mixture of same is used as extractant. Applications for the method include the processing of spent nuclear fuels, in particular comprising uranium (e.g. UOX) or uranium and plutonium (e.g. MOX).

The present invention provides cationic lipids and lipid nanoparticle formulations comprising these lipids, alone or in combination with other lipids. These lipid nanoparticles may be formulated with nucleic acids to facilitate their intracellular delivery both in vitro and for therapeutic applications. The present invention also provides methods of chemical synthesis of these lipids, lipid nanoparticle preparation and formulation with nucleic acids.